CHARLES WATRAS: Open Payments
NPI 1891772737 · MURPHY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 23 payments from 9 companies in 2025. Trend: 2023 $899 · 2024 $746 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $111 |
| Novo Nordisk Inc | 3 | $57 |
| Corcept Therapeutics | 3 | $51 |
| ABBVIE INC. | 3 | $50 |
| Exact Sciences Corporation | 2 | $33 |
| Amgen Inc. | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Lilly USA, LLC | 1 | $21 |
| Viatris Specialty LLC | 1 | $21 |
Products named: Ozempic, Korlym, VRAYLAR, FARXIGA, AIRSUPRA, Cologuard Collection Kit, OTEZLA, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
